Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rai, Bhavan
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms	Active, not recruiting	2	433	Europe	Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)	Imperial College London, Wellcome Trust	Prostate Cancer, Metastatic Prostate Cancer	08/26	01/27
IP5-MATTER, NCT04590976: Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research	Completed	N/A	320	Europe	Semi-Structured Interview Healthcare Professional, Semi-Structured Interview Patients, Think Aloud Interview Patients, Discrete Choice Experiment (DCE) Patients	Imperial College London, University of Aberdeen	Prostate Cancer Metastatic, Radiotherapy Side Effect, Surgery, Urologic Cancer, Quality of Life, Patient Satisfaction, Health Care Utilization	02/23	02/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rai, Bhavan
IP2-ATLANTA, NCT03763253: Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms	Active, not recruiting	2	433	Europe	Standard of Care, Minimally Invasive Ablative Therapy (MIAT), Metastatic Directed Therapy (MDT), Radical Therapy (Prostatectomy or Radiotherapy)	Imperial College London, Wellcome Trust	Prostate Cancer, Metastatic Prostate Cancer	08/26	01/27
IP5-MATTER, NCT04590976: Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research	Completed	N/A	320	Europe	Semi-Structured Interview Healthcare Professional, Semi-Structured Interview Patients, Think Aloud Interview Patients, Discrete Choice Experiment (DCE) Patients	Imperial College London, University of Aberdeen	Prostate Cancer Metastatic, Radiotherapy Side Effect, Surgery, Urologic Cancer, Quality of Life, Patient Satisfaction, Health Care Utilization	02/23	02/23